Effective holistic characterization of small molecule effects using heterogeneous biological networks
The two most common reasons for attrition in therapeutic clinical trials are efficacy and safety. We integrated heterogeneous data to create a human interactome network to comprehensively describe drug behavior in biological systems, with the goal of accurate therapeutic candidate generation. The Co...
Main Authors: | William Mangione, Zackary Falls, Ram Samudrala |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1113007/full |
Similar Items
-
Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform
by: Matthew L. Hudson, et al.
Published: (2021-04-01) -
Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease
by: Manoj J. Mammen, et al.
Published: (2022-05-01) -
Drug repurposing and phenotypic screening: innovative strategies for treating ultra-rare disorders
by: Adrien Paquot, et al.
Published: (2024-10-01) -
The Role of Organic Small Molecules in Pain Management
by: Sebastián A. Cuesta, et al.
Published: (2021-07-01) -
A Deep-Learning Proteomic-Scale Approach for Drug Design
by: Brennan Overhoff, et al.
Published: (2021-12-01)